The new vaccine aims to provide protection against all four dengue serotypes. Read more at straitstimes.com. Read more at ...

Seongnam, South Korea Saturday, July 19, 2025, 12:00 Hrs [IST] ...

Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...

Prescient Therapeutics has signalled its position as one of the most advanced oncology companies on the ASX, according to ...

Compelling new preliminary data consistent with previously reported preclinical findings demonstrating certepetide’s potential ability to enhance the effectiveness of immunotherapy ...

Investors look at many variables when deciding which stocks to buy, including a company's industry. If an industry is exhibiting high growth, stocks in that sector can gain value. It' ...

Company aims for technology advancement and platform expansion with Korea's first influenza vaccine using an adjuvant Interim ...

These capabilities illustrate the multifaceted promise of AI: speeding up scientific discovery, improving patient outcomes, ...

Oncology biotech Prescient Therapeutics (ASX: PTX) has announced the completion of its first US site visit for its Phase 2a ...

WEHI has formed a partnership with the Parkinson's Research Foundation with one clear goal: to intensify the search for drug treatments to stop ...

The newly approved linvoseltamab (Lynozyfic; Regeneron) has a manageable safety profile, along with a patient-friendly dosing ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...